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Abstract 
 
Protein profiling with high-throughput proteomic technology, SELDI-TOF, is a new potential tool for diagnosis of 
human diseases. This advanced technique has increasingly been used for the detection of disease biomarker. However, 
analytical reproducibility is a significant challenge in SELDI-TOF profiling in order to have confidence in the results.  
Here, we showed a simple step to improve its analytical performance. IMAC 30-Cu Protein Chip was used to incubate 
denaturated samples to increase the number of peak detection and decrease peak intensity coefficient of variation. 
Incubation of denaturated samples overnight at 4oC increased significantly reproducibility and quality of proteomic 
profile of SELDI-TOF MS for IMAC30-Cu ProteinChip. This strategy could be applied to address reproducibility issue 
in protemictechnology in protein profiling.   
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1. Introduction 
 
Protein profiling with surface-enhanced laser 
desorption-ionisation time-of-flight mass spectrometry 
(SELDI-TOF MS) is a promising approach for 
biomarker discovery. The resolution of this advanced 
technology has been improved by incorporating 
fractionation and a variety of affinity capture 
technique. 1 Recently, SELDI-TOF protein profiling has 
been applied in many proteomic biomarker researches 
such as cancer and infectious disease that reveal high 
diagnostic sensitivities and specificities. Although it is a 
robust platform for protein profiling, some sources of 
technical and non-technical variation make reproducing 
and validating potential biomarker challenging.2,3 As 
with any proteomic analysis, it is still required for 
optimization of experimental procedure to ensure 
consistent data output. Confidence that differences in 
SELDI-TOF profile pattern specifically reflect changes 
in protein concentration is dependent in part on spectra 
reproducibility and quality, and these parameters are 
affected by multiple variables.4 Sample preparation 
procedure is one of important factor to give a better 
quality, reproducible and robust output of proteomic 
profile of SELDI-TOF MS.5 Here, we perform a simple 
step to increased robustness of the technique. We 
showed that by using IMAC30-Cu ProteinChip, 
incubation of denaturated samples increased 
significantly the number of peak detection and 
decreased peak intensity coefficient of variation (CV). 
This strategy could be used as an alternative technique 
to address reproducibility issue in this system. 
 
2. Methods 
 
Serum Samples. Blood from 5 healthy volunteers were 
collected in Vacutainer tube without additive, let it clot 
in 30 minutes at room temperature and centrifuges for 
30 minutes at 3000 rpm. Serums were recovered, pooled 
and frozen at minus 80oC until used. 
 
SELDI Protein Profiling. For SELDI analysis, we use 
two ProteinChips Arrays (Ciphergen Biosystems, Inc), 
immobilized affinity capture (IMAC30) and weak 
cation exchage (CM10). Serum samples are processed 
as previously described with minor modification.6 
Samples were prepared in ice by mixing 20 uL serum 
with 30 uL U9 buffer (9 M urea, 2% CHAPS, in 100 
mM Tris pH 9) in a 1.5 mL microfuge tube at 4oC for 10 
minutes and were shaked for 30-45 minutes at room 
temperature. Then, 2 uL serum/U9 buffer was diluted 
with 98 uL corresponding binding buffer (PBS 1X + 0.5 
M NaCl for IMAC30 and 100 mM Na acetate pH 4 +/- 
Triton X for CM10). Denaturated samples were then 
stored (incubated) in 4oC overnight. For control 
(treatment without incubation), denaturated samples 
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were spotted directly to the arrays. The ProteinChips 
Arrays were assembled into a deep-well type 
bioprocessor (Ciphergen Biosystems, Inc.). Prior to 
sample loading, IMAC30 were coated with CuSO4  by 
adding 50 μL of 100 mM CuSO4 to each arrays. After 
10 min agitation on platform shaker at a speed of 250 
rpm for 10 minutes, the arrays were quickly rinsed with 
DI water to removed unbound metal. To remove 
unbound copper, 50 μL sodium acetate solution pH 4 
was added to each array and shaken for 5 minutes and 
rinsed again with DI water. The arrays were then 
equilibrated with 150 μL of binding buffer (PBS). Prior 
to sample loading, CM10 arrays were equilibrated with 
150 μL of corresponding binding buffer (50 mM 
sodium acetate pH 4.0). Arrays were spotted with 50 μL 
of diluted sample for 30 min on a shaker at 250 rpm and 
washed three times with 150 μL corresponding binding 
buffer. After rinsing with DI water, the arrays were 
removed from the bioprocessor assembly and air dried. 
CHCA (Ciphergen Biosystems, Inc, Cat. No. C300-
0002) as energy absorbing matrix was prepared 
according to the manufacturer’s instruction in 50% v/v 
acetonitrile/5% v/v trifluoroacetic acid and 0.5 μL of the 
saturated solution applied twice to each spot on the chip. 
We used CHCA because this matrix gave best 
proteomic profile in molecular mass 3-15 kDa which 
become our and many other studies’ concern in 
identification of biomarker. ProteinChip arrays were 
analyzed in the ProteinChip Biology System reader 
(Model PBS II, Ciphergen Biosystem) and the data were 
analyzed by ProteinChip Software version 3.0. 
 
3. Results and Discussion 
 
In biomarker study with SELDI-TOF protein profiling 
the aim is to identify peak intensity (or peaks area) that 
are different between case and control samples and thus 
reproducibility of peak intensities is of highest 
importance. Despite promising, SELDI-TOF analysis on 
biological specimen such as serum remain challenging 
due to its complexity. Much has been discussed in 
SELDI-TOF technology concerning its long-term 
robustness, the contribution of non-biological variation 
to the result and the need for better quality control.7 One 
of the most critical issue of this technique is 
reproducibility of the data that is critical in biomarker 
identification and validation. Several studies addressed 
this issue have been looking at the impact of some 
preanalytical variables such as blood sample processing2, 
and standardization analytical condition.8,9 To ensure 
consistent data output, procedures or stringent protocol 
that have been optimized and reproducible is an urgent 
need. The main thrust of this work was to develop 
enhanced protocol to minimize variability of data 
caused by preanalytical variables. Here we describe a 
simple step to improved proteomic profiles and 
reproducibility of peaks detection as determined by 
number of peaks and signal intensity coefficient of 
variance (CVs) on a QC sample (pooled normal serum). 
To calculate CV of peak intensity, all peak detected in 
each experiment were used. It was shown that by 
incubating denaturated samples overnight in 4oC, in 
general, robustness of the technique was increased for 
IMAC30-Cu as demonstrated by reproducibility and 
number of peak detected  (Table 1 and Figure1). 
 
The average of CV was decreased from 18.5 (without 
incubation) to 13.9 (o/n incubation) (p<0,05) and the 
average of number of peak was increased from 30 
(without incubation) to 50 (o/n incubation) (p<0.01).  
For CM10, although incubation treatment seemed to 
have positive effect on proteomic profile quality, the 
improvement were not statistically significant. We also 
found that some peaks were detected higher by 
increasing of the incubation time (30 minutes and 4 
hours h Vs Versus O/N), however contrary effect was 
shown in some other peaks (Figure 2 and 3). IMAC30-
Cu and CM10 ProteinChip were widely used in 
biomarker study for infectious disease such as 
AfricanTrypanosomiasis,10 SARS11 and cancers like 
ovarian.12 and lung cancers.6 These two arrays give 
more peaks compared to other Chip available. 
 
This simple step described in this work could be taken 
together with other strategies to address reliable 
proteomic data developed by some other studies. Since 
validation of disease biomarker relies on optimized and 
reproducible laboratory methods, such work is of 
importance. Further study, that focus on investigating 
the effect on other Protein Chip arrays is needed.   
 
Table 1.  Reproducibility and Quality of Proteomic 
Profiles in IMAC30-Cu and CM10 ProteinChip 
Arrays were Shown Increased with Overnight 
Incubation Treatment 
 
Exp  %CV  
p<0,05)a 
   Number of 
     (p<0.01)a 
Peak 
Array IMAC30 
 w/o in-
cubation 
o/n incu- 
bation 
w/o in-
cubation 
o/n incu- 
bation 
I 21.4    11.6 40 49 
II 13.7    11.8 39 50 
III 16.8    14.0 39 51 
IV 17.9   12.7 35 49 
V 20.8   18.1 37 47 
VI 20.6   15.5 42 50 
 18.5   13.9 39 50 
Array CM10    
I 18.0    12.8 37 40 
II 20.8    18.1 35 45 
 19.4   10.4b 36 43b 
aCalculated by the non-parametric One-Way Anova 
bStatistically not significant 
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Figure 1.   Effect of Overnight Incubation to Proteomic Profile in IMAC30-Cu arrays. Spectra Ranged 0-20.000 Da (A); 
Some Peaks (Ranged 3000-4000 Da) were Detected Higher in Incubated Samples Compared to un-Incubated 
Samples (B); Gel View (C)   
 
 
 
 
 
Figure 2.   Effect of Incubation Time of Denatured Samples in Proteomic Profiles for IMAC30-Cu Arrays. Two Peaks (2872 
and 3162) were Detected Higher in Samples Incubated for 4 h, and Over Night). However Peak of 2968 and 3321 
were Decreased by Longer Incubation (4 h, and over night) (A); The same Phenomenon was also Shown some 
other Peaks (B) 
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Figure 3. Effect of Incubation Time in Proteomic Profiles, Ranged 6000-7500 Da (A); Gel View (B) 
 
 
4. Conclusion 
 
For IMAC30-Cu, overnight incubation of denaturated 
samples at 4oC were shown to increased reproducibility 
and quality of proteomic profiles of SELDI-TOF MS. 
This were shown by significantly decreasing in peak 
intensity coefficient of variant (CV) and increasing 
number of peak detection, respectively. This strategy 
could become a simple step to address reproducibility 
issue in this proteomic technology.   
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